Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases

Nature Structural and Molecular Biology

Volumn 20, Issue 4, 2013, Pages 502-507

  Rosenthal, Florian ^a   Feijs, Karla L H ^b   Frugier, Emilie ^a   Bonalli, Mario ^a   Forst, Alexandra H ^b   Imhof, Ralph ^a   Winkler, Hans C ^a   Fischer, David ^a   Caflisch, Amedeo ^a   Hassa, Paul O ^a   Lüscher, Bernhard ^b   Hottiger, Michael O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSYLHYDROLASE; GLYCOGEN SYNTHASE KINASE 3BETA; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CATALYSIS; HUMAN; HYDROLYSIS; IN VITRO STUDY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE DIPHOSPHATE RIBOSE; HUMANS; MODELS, MOLECULAR; MUTAGENESIS; N-GLYCOSYL HYDROLASES;

ARCHAEA; HOMO SAPIENS;

EID: 84876167387     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2521     Document Type: Article

References (40)

1. Erener, S. et al. ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation. FASEB J. 26, 2631-2638 (2012).
2. Altmeyer, M. & Hottiger, M.O. Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and infammation in aging. Aging 1, 458-469 (2009).
3. Hassa, P.O., Haenni, S., Elser, M. & Hottiger, M.O. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol. Mol. Biol. Rev. 70, 789-829 (2006).
4. Telli, M.L. PARP inhibitors in cancer: moving beyond BRCA. Lancet Oncol. 12, 827-828 (2011).
5. Curtin, N.J. PARP inhibitors for cancer therapy. Expert Rev. Mol. Med. 7, 1-20 (2005).
6. Schreiber, V., Dantzer, F., Ame, J.-C. & De Murcia, G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7, 517-528 (2006).
7. Kleine, H. et al. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell 32, 57-69 (2008).
8. Feijs, K.L.H. et al. ARTD10 substrate identifcation on protein microarrays: regulation of GSK3β by mono-ADP-ribosylation. Cell Commun. Signal published online, doi:10.1186/1478-811X-11-5 (19 January 2013).
9. Hottiger, M.O., Hassa, P.O., Lüscher, B., Schüler, H. & Koch-Nolte, F. Toward a unifed nomenclature for mammalian ADP- ribosyltransferases. Trends Biochem. Sci. 35, 208-219 (2010).
10. Hanai, S. et al. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 101, 82-86 (2004).
11. Koh, D.W. et al. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc. Natl. Acad. Sci. USA 101, 17699-17704 (2004).
12. Williams, J.C., Chambers, J.P. & Liehr, J.G. Glutamyl ribose 5-phosphate storage disease. A hereditary defect in the degradation of poly(ADP-ribosylated) proteins. J. Biol. Chem. 259, 1037-1042 (1984).
13. Slade, D. et al. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477, 616-620 (2011).
14. Dunstan, M.S. et al. Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase. Nat. Commun. 3, 878 (2012).
15. Han, W., Li, X. & Fu, X. The macro domain protein family: structure, functions, and their potential therapeutic implications. Mutat. Res. 727, 86-103 (2011).
16. Kim, I.K. et al. Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a fexible tyrosine clasp as a substrate-binding element. Nat. Struct. Mol. Biol. 19, 653-656 (2012).
17. Karras, G.I. et al. The macro domain is an ADP-ribose binding module. EMBO J. 24, 1911-1920 (2005).
18. Neuvonen, M. & Ahola, T. Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J. Mol. Biol. 385, 212-225 (2009).
19. Angelov, D. et al. The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol. Cell 11, 1033-1041 (2003).
20. Buschbeck, M. et al. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol. 16, 1074-1079 (2009).
21. Changolkar, L.N. et al. Developmental changes in histone macroH2A1-mediated gene regulation. Mol. Cell Biol. 27, 2758-2764 (2007).
22. Goenka, S., Cho, S.H. & Boothby, M. Collaborator of Stat6 (CoaSt6)-associated poly(ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription. J. Biol. Chem. 282, 18732-18739 (2007).
23. Ahel, D. et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325, 1240-1243 (2009).
24. Gottschalk, A.J. et al. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc. Natl. Acad. Sci. USA 106, 13770-13774 (2009).
25. Aguiar, R.C., Takeyama, K., He, C., Kreinbrink, K. & Shipp, M.A. B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J. Biol. Chem. 280, 33756-33765 (2005).
26. Aguiar, R.C. et al. BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 96, 4328-4334 (2000).
27. Cho, S.H. et al. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proc. Natl. Acad. Sci. USA 108, 15972-15977 (2011).
28. Chen, D. et al. Identifcation of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J. Biol. Chem. 286, 13261-13271 (2011).
29. Peterson, F.C. et al. Orphan macrodomain protein (human C6orf130) is an O-acyl-ADP-ribose deacylase: solution structure and catalytic properties. J. Biol. Chem. 286, 35955-35965 (2011).
30. Hofmann, A. et al. Structure and mechanism of activity of the cyclic phosphodiesterase of Appr
31. Sawaya, R., Schwer, B. & Shuman, S. Structure-function analysis of the yeast NAD+-dependent tRNA 2′-phosphotransferase Tpt1. RNA 11, 107-113 (2005).
32. Stone, P.R. & Hilz, H. Quantitation of hydroxylamine sensitive mono(adenosine diphosphate ribose) residues in different hepatic tissues. FEBS Lett. 57, 209-212 (1975).
33. Barth, H., Aktories, K., Popoff, M.R. & Stiles, B.G. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 68, 373-402 (2004).
34. Lang, A.E. et al. Photorhabdus luminescens toxins ADP-ribosylate actin and RhoA to force actin clustering. Science 327, 1139-1142 (2010).
35. Timinszky, G. et al. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat. Struct. Mol. Biol. 16, 923-929 (2009).
36. Jope, R.S. & Johnson, G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102 (2004).
37. Jackson, M.D. & Denu, J.M. Structural identifcation of 2′-and 3′-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of β-NAD+-dependent histone/protein deacetylases. J. Biol. Chem. 277, 18535-18544 (2002).
38. Sauve, A.A. et al. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry 40, 15456-15463 (2001).
39. Jackson, M.D., Schmidt, M.T., Oppenheimer, N.J. & Denu, J.M. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J. Biol. Chem. 278, 50985-50998 (2003).
40. Kleine, H. et al. Dynamic subcellular localization of the mono-ADP-ribosyltransferase ARTD10 and interaction with the ubiquitin receptor p62. Cell Commun. Signal. 10, 28 (2012).